Latest News

You can take a set-it-and-forget-it approach with these two industry leaders.

Since becoming CEO, Ryan Cohen has redefined GameStop's business and invested company funds outside of retailing.

Prediction markets offer a unique way to make money, even if top cryptocurrencies are in the red.

Achieving a perfect 850 credit score takes decades. But you can copy the same habits and still get top loan rates and credit cards.

Pfizer has fallen behind the pack when it comes to GLP-1 drugs, but the company is still fighting.

They are great long-term options.

You may not be able to predict exactly how long you'll live, but it's a good idea to plan for a longer-than-expected life.

The conglomerate is still the ultimate sleep-well-at-night stock.

There are still trends playing in its favor in 2026.

A 10% owner of Under Armour purchased multiple shares of the company towards the end of January 2026. Is this a signal to purchas UA stock?

The Vanguard Information Technology ETF gives investors positions in leading tech companies, but it comes with risk.

Consumer staples stocks being out of favor is an impeccable buying opportunity for value investors.

The market keeps rewarding this business, as shares benefit from positive momentum.

Don't invest in the SpaceX IPO until you understand the Starlink business.

XRP was above $3 in 2025, and it might soon be once again.

All three of these AI stocks should have tremendous momentum this year.

These AI stocks are inexpensive for a simple reason: They should grow by leaps and bounds.

Can Peloton be the year's biggest turnaround story?

There's a reason many retirees may be disappointed in their benefits this year.

Maze Therapeutics' Senior Vice President of Finance sold shares towards the end of January 2026, all while the company's stock had one of the best first-year performances of a biopharmaceutical company.

Workers with median earnings can build sizable portfolios that pay a substantial amount of passive income.

Costco and Walmart are two of the world's largest retailers.

Wall Street's foundational financial institution is rife with red flags, and the stock market could pay the price.

Beam Therapeutics specializes in gene-editing medicines, and recently, the company's Senior Vice President edited out thousands of shares from her portfolio.

These Vanguard funds won't necessarily keep you from losing money if the market crashes. But they can help cushion the blow.